215 related articles for article (PubMed ID: 17456825)
1. Does ranolazine have a place in the treatment of acute coronary syndromes?
Newby LK; Peterson ED
JAMA; 2007 Apr; 297(16):1823-5. PubMed ID: 17456825
[No Abstract] [Full Text] [Related]
2. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
[TBL] [Abstract][Full Text] [Related]
3. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine as add-on therapy for patients with severe chronic angina.
Pechlaner C; Wiedermann C
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113811
[No Abstract] [Full Text] [Related]
5. Ranolazine as add-on therapy for patients with severe chronic angina.
Hooper JS; Busti AJ
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113810
[No Abstract] [Full Text] [Related]
6. Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.
Conti CR
Clin Cardiol; 2008 Jul; 31(7):295-6. PubMed ID: 18636470
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
[TBL] [Abstract][Full Text] [Related]
8. [Angina pectoris. Ranolazine is effective in myocardial ischemia therapy].
MMW Fortschr Med; 2013 Oct; 155(18):74-5. PubMed ID: 24288929
[No Abstract] [Full Text] [Related]
9. Ranolazine in patients with angina and coronary artery disease.
Scirica BM; Morrow DA
Curr Cardiol Rep; 2007 Jul; 9(4):272-8. PubMed ID: 17601393
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine--a nicely timed new medical therapy for stable angina.
Jackson G
Int J Clin Pract; 2007 Jul; 61(7):1063. PubMed ID: 17577287
[No Abstract] [Full Text] [Related]
11. [Ranolazine--new treatment of chronic stable angina pectoris].
Ahlehoff O; Hansen PR
Ugeskr Laeger; 2009 Dec; 171(50):3705-7. PubMed ID: 20003868
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine and the myocardial demand-supply balance.
Klocke FJ
JACC Cardiovasc Imaging; 2009 Nov; 2(11):1310-2. PubMed ID: 19909935
[No Abstract] [Full Text] [Related]
13. Ranolazine: a novel therapeutic option in chronic stable angina.
Jose J; Jimmy B; Saravu K; Shastry BA
Kathmandu Univ Med J (KUMJ); 2007; 5(4):596-9. PubMed ID: 18604102
[No Abstract] [Full Text] [Related]
14. At the dawn of a new era in treating angina pectoris, or just another antianginal drug? Some considerations about ranolazine.
Bălan H
Rom J Intern Med; 2010; 48(4):361-9. PubMed ID: 21528766
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine: focusing on angina pectoris.
McCullough PA
Drugs Today (Barc); 2006 Mar; 42(3):177-83. PubMed ID: 16628259
[TBL] [Abstract][Full Text] [Related]
16. Ranolazine for the management of coronary artery disease.
Cheng JW
Clin Ther; 2006 Dec; 28(12):1996-2007. PubMed ID: 17296457
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine and other antianginal therapies in the era of the drug-eluting stent.
Berger P
JAMA; 2004 Jan; 291(3):365-7. PubMed ID: 14734600
[No Abstract] [Full Text] [Related]
18. Utility of ranolazine in chronic stable angina patients.
Patel PD; Arora RR
Vasc Health Risk Manag; 2008; 4(4):819-24. PubMed ID: 19065998
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
Mega JL; Hochman JS; Scirica BM; Murphy SA; Sloan S; McCabe CH; Merlini P; Morrow DA
Circulation; 2010 Apr; 121(16):1809-17. PubMed ID: 20385930
[TBL] [Abstract][Full Text] [Related]
20. [Ranolazine--an additional anti-anginal drug].
Michels G; Kochanek M; Hoppe UC
Dtsch Med Wochenschr; 2010 Oct; 135(41):2037-40. PubMed ID: 20925013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]